542P - Factors related to the delay of medical treatment of Indonesian cancer patients

Date 18 December 2016
Event ESMO Asia 2016 Congress
Session Poster lunch
Presenter Catherine Gunawan
Citation Annals of Oncology (2016) 27 (suppl_9): ix170-ix176. 10.1093/annonc/mdw599
Authors C. Gunawan1, A.D. Vatvani1, K. Waren1, A. Kurniawan2
  • 1Medical Student, Siloam Hospital/Medical faculty of Pelita Harapan University, 15811 - Tangerang/ID
  • 2Internal Medicine, Siloam Hospital/Medical faculty of Pelita Harapan University, 15811 - Tangerang/ID

Abstract

Background

Delay of medical treatment in cancer patients causes decrease in survival rates, increase in morbidity and mortality rate, and the occurence of metastasis. There are several studies which have reported factors related to delay of medical treatment in cancer patients. But there is limited data regarding those factors in Indonesia. The aim of this study is to identify factors affecting treatment delay (TD) in Indonesian cancer patients.

Methods

Adult solid tumor patients were enrolled in this observational cross-sectional study. Baseline characteristics of patients such as age, sex, level of education, income, travel time to hospital, family history of cancer, cancer screening history, visit to alternative medicine, and types of cancer were evaluated. Presence of denial to cancer diagnosis was evaluated as the cause of treatment delay. We used Mental Adjustment to Cancer Scale questionnaire to evaluate those problems. Patients were classified as treatment delayed if the time from diagnosis to first medical treatment was more than 1 month.

Results

There were 61 cancer patients enrolled with median of age of 50 (19-75) years. Mostly, the level of education was primary school, 31.1%. Predominantly, the sex was female, 90.2%. Mainly, the income was 2.5-5 million Indonesian Rupiahs, 41.0%. Mostly, travel time to hospital was less than 2 hours, 96.7%. Family history of cancer was 24.6%. Cancer screening history was 8.2%, p value 0.044. Visit to alternative medicine was 32.8%. Mainly, the type of cancer was breast cancer, 80.3%. Mostly, the patients care about their cancer, 42.6%, p value 0.045. Median delay time was 29 days. Factors significantly affecting treatment delay were previous cancer screening history and patients’ attitude to their cancer. The other factors were not statistically significant.

Conclusions

Factors significantly affecting treatment delay were previous cancer screening history and patients’ attitude to their cancer.

Clinical trial indentification

Legal entity responsible for the study

Mochtar Riady Institute for Nanotechnology Ethics Committee

Funding

Faculty of Medicine, Pelita Harapan University

Disclosure

All authors have declared no conflicts of interest.